Korea United Pharm Inc.
KRX:033270.KS
20800 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 278,943.297 | 262,522.023 | 221,039.963 | 215,949.553 | 221,310.875 | 211,935.53 | 197,023.264 | 176,905.09 | 162,045.985 | 155,189.553 | 136,891.13 | 134,829.851 | 145,453.053 | 134,958.313 | 119,084.235 | 94,700.346 | 59,695.984 | 67,591.173 |
| Cost of Revenue
| 105,455.242 | 117,234.413 | 98,380.223 | 90,757.558 | 92,723.06 | 86,458.791 | 85,161.743 | 80,075.247 | 74,526.748 | 72,097.342 | 64,725.776 | 59,453.088 | 56,066.649 | 48,895.432 | 39,809.889 | 27,916.777 | 17,709.536 | 21,150.521 |
| Gross Profit
| 173,488.055 | 145,287.609 | 122,659.74 | 125,191.994 | 128,587.814 | 125,476.738 | 111,861.521 | 96,829.843 | 87,519.237 | 83,092.21 | 72,165.354 | 75,376.763 | 89,386.404 | 86,062.881 | 79,274.346 | 66,783.569 | 41,986.448 | 46,440.652 |
| Gross Profit Ratio
| 0.622 | 0.553 | 0.555 | 0.58 | 0.581 | 0.592 | 0.568 | 0.547 | 0.54 | 0.535 | 0.527 | 0.559 | 0.615 | 0.638 | 0.666 | 0.705 | 0.703 | 0.687 |
| Reseach & Development Expenses
| 33,197.231 | 15,535.632 | 13,791.51 | 12,269.218 | 14,099.249 | 12,442.087 | 4,899.842 | 4,005.038 | 3,803.307 | 3,988.619 | 3,004.794 | 1,299.043 | 1,271.625 | 1,529.79 | 1,195.739 | 1,888.693 | 1,844.677 | 2,233.282 |
| General & Administrative Expenses
| 16,011.738 | 16,138.839 | 17,131.189 | 16,923.265 | 19,945.418 | 20,192.595 | 19,949.586 | 19,415.392 | 18,044.817 | 17,342.751 | 16,301.666 | 15,985.083 | 18,927.034 | 23,391.36 | 26,572.253 | 28,210.368 | 13,280.074 | 11,638.369 |
| Selling & Marketing Expenses
| 20,743.207 | 18,549.041 | 16,684.482 | 15,984.879 | 18,943.336 | 14,797.106 | 14,385.274 | 12,305.865 | 11,165.819 | 11,531.141 | 11,230.428 | 11,551.718 | 12,828.165 | 13,279.234 | 12,636.264 | 11,172.278 | 8,615.372 | 9,422.973 |
| SG&A
| 83,228.128 | 34,687.88 | 33,815.671 | 32,908.144 | 38,888.754 | 34,989.701 | 34,334.86 | 31,721.257 | 29,210.636 | 28,873.892 | 27,532.094 | 27,536.801 | 31,755.199 | 36,670.594 | 39,208.517 | 39,382.646 | 21,895.446 | 21,061.342 |
| Other Expenses
| -1,788.936 | 46,850.935 | 41,827.243 | 39,888.694 | 40,600.987 | 2,761.914 | 138.082 | 476.857 | 1,008.871 | 106.617 | 991.127 | 1,987.324 | 716.273 | -1,614.314 | -2,375.939 | -684.731 | -118.035 | -402.5 |
| Operating Expenses
| 118,214.295 | 97,074.447 | 89,434.424 | 85,066.056 | 93,588.99 | 87,726.136 | 80,144.443 | 69,711.626 | 64,604.556 | 61,105.241 | 57,328.173 | 55,566.649 | 66,526.363 | 64,307.408 | 60,056.188 | 54,552.909 | 34,965.418 | 39,333.95 |
| Operating Income
| 55,273.759 | 48,213.162 | 33,225.316 | 40,125.938 | 34,479.474 | 37,750.603 | 31,717.078 | 27,118.217 | 22,914.681 | 21,986.969 | 14,837.181 | 19,810.114 | 23,577.551 | 21,755.474 | 19,218.159 | 12,230.661 | 7,021.032 | 7,106.703 |
| Operating Income Ratio
| 0.198 | 0.184 | 0.15 | 0.186 | 0.156 | 0.178 | 0.161 | 0.153 | 0.141 | 0.142 | 0.108 | 0.147 | 0.162 | 0.161 | 0.161 | 0.129 | 0.118 | 0.105 |
| Total Other Income Expenses Net
| 3,794.022 | 5,211.653 | 6,257.912 | -4,475.657 | 4,054.559 | 2,187.972 | -3,199.695 | 338.465 | 1,926.527 | 792.583 | 731.77 | 751.715 | -852.214 | -2,441.367 | -3,948.488 | -1,446.715 | -692.253 | -2,181.999 |
| Income Before Tax
| 59,067.781 | 53,424.815 | 39,483.228 | 35,650.282 | 38,534.033 | 39,938.575 | 28,517.383 | 27,456.682 | 24,841.208 | 22,779.552 | 15,568.951 | 20,561.829 | 22,725.338 | 19,314.107 | 15,269.671 | 10,783.946 | 6,328.779 | 4,924.704 |
| Income Before Tax Ratio
| 0.212 | 0.204 | 0.179 | 0.165 | 0.174 | 0.188 | 0.145 | 0.155 | 0.153 | 0.147 | 0.114 | 0.153 | 0.156 | 0.143 | 0.128 | 0.114 | 0.106 | 0.073 |
| Income Tax Expense
| 11,821.92 | 8,149.721 | 10,834.479 | 9,037.025 | 7,618.086 | 8,266.127 | 653.732 | 7,942.918 | 3,119.775 | 4,300.221 | 3,364.732 | 4,191.411 | 2,527.926 | 2,470.652 | 1,070.105 | 1,909.551 | 753.252 | 973.947 |
| Net Income
| 48,261.714 | 45,275.094 | 28,648.749 | 26,613.257 | 30,915.946 | 31,672.447 | 27,863.651 | 19,513.765 | 21,721.433 | 18,374.836 | 12,212.392 | 16,378.83 | 20,208.058 | 16,843.455 | 14,199.566 | 8,874.396 | 5,575.526 | 3,950.757 |
| Net Income Ratio
| 0.173 | 0.172 | 0.13 | 0.123 | 0.14 | 0.149 | 0.141 | 0.11 | 0.134 | 0.118 | 0.089 | 0.121 | 0.139 | 0.125 | 0.119 | 0.094 | 0.093 | 0.058 |
| EPS
| 3,297.93 | 3,057.78 | 1,930.09 | 1,793.76 | 2,086.92 | 2,139.2 | 1,882 | 1,277 | 1,384 | 1,163 | 759.8 | 1,059.8 | 1,398.04 | 1,127.45 | 932.35 | 591.18 | 372.55 | 266.67 |
| EPS Diluted
| 3,277.48 | 3,038.18 | 1,917.77 | 1,787.06 | 2,086.16 | 2,139 | 1,882 | 1,277 | 1,384 | 1,160 | 750.98 | 1,059.8 | 1,386.27 | 1,112.75 | 922.55 | 591.18 | 371.57 | 266.67 |
| EBITDA
| 65,367.935 | 69,734.612 | 51,942.124 | 48,744.639 | 49,902.829 | 52,207.036 | 36,964.716 | 37,126.876 | 31,796.799 | 30,936.389 | 22,765.17 | 26,595.69 | 28,558.464 | 24,667.968 | 20,438.237 | 15,673.68 | 10,026.064 | 9,599.682 |
| EBITDA Ratio
| 0.234 | 0.266 | 0.235 | 0.226 | 0.225 | 0.246 | 0.188 | 0.21 | 0.196 | 0.199 | 0.166 | 0.197 | 0.196 | 0.183 | 0.172 | 0.166 | 0.168 | 0.142 |